OptimizeRx Corp (OPRX) insider trading.
In Q3 2026, insiders at OptimizeRx Corp reported 10 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 10
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 5
- Last filed
- 2026-09-02
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| D'Silva Andrew J. | Officer · Chief Business Officer | 3 | 0 | 0 |
| Odence-Ford Marion | Officer · Chief Legal & Admin Officer | 2 | 0 | 0 |
| Silvestro Stephen L | Officer · Chief Executive Officer | 2 | 0 | 0 |
| Merrell Brendan W. | Officer · CHIEF OPERATING OFFICER | 2 | 0 | 0 |
| Stelmakh Edward | Officer · Chief Finance & Strat Officer | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-01 | D'Silva Andrew J. | F (D) | 1,432 | $7.86 | 99,660 | Form 4 |
| 2026-08-21 | Stelmakh Edward | F (D) | 1,381 | $7.71 | 121,791 | Form 4 |
| 2026-08-21 | D'Silva Andrew J. | F (D) | 1,243 | $7.71 | 43,492 | Form 4 |
| 2026-08-21 | Odence-Ford Marion | F (D) | 1,529 | $7.71 | 90,407 | Form 4 |
| 2026-08-21 | Silvestro Stephen L | F (D) | 1,737 | $7.71 | 183,551 | Form 4 |
| 2026-08-21 | Merrell Brendan W. | F (D) | 1,020 | $7.71 | 25,187 | Form 4 |
| 2026-08-20 | Odence-Ford Marion | A (A) | 57,600 | $0 | 148,007 | Form 4 |
| 2026-08-20 | Merrell Brendan W. | A (A) | 57,600 | $0 | 82,787 | Form 4 |
| 2026-08-20 | D'Silva Andrew J. | A (A) | 57,600 | $0 | 101,092 | Form 4 |
| 2026-08-20 | Silvestro Stephen L | A (A) | 79,200 | $0 | 262,751 | Form 4 |
Transaction codes in this quarter
Get OPRX insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1448431&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · OPRX company page · OptimizeRx Corp on SEC.gov
Questions
Are insiders buying or selling OptimizeRx Corp (OPRX)?
In Q3 2026, insiders at OptimizeRx Corp reported 10 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these OptimizeRx Corp insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/oprx.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.